Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B L Pentecost

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Lancet (London, England)|April 17, 1993
Proteinuria with streptokinaseM Lynch, B L Pentecost, W A Littler, et al.
British Heart Journal|August 1, 1991
Immunoglobulin response to intravenous streptokinase in acute myocardial infarctionM Lynch, W A Littler, B L Pentecost, et al.
Clinical and Experimental Immunology|June 1, 1994
The significance of anti-streptokinase antibodiesM Lynch, B L Pentecost, W A Littler, et al.
British Heart Journal|November 1, 1970
Quantitative study of infarcted myocardium in cardiogenic shockC Harnarayan, M A Bennett, B L Pentecost, et al.
Lancet (London, England)|April 15, 1972
Trial of combined intramuscular and intravenous lignocaine in prophylaxis of ventricular tachyarrhythmiasS Darby, J C Cruickshank, M A Bennett, et al.
Clinical and Experimental Immunology|November 1, 1993
Why do patients develop reactions to streptokinase?M Lynch, B L Pentecost, W A Littler, et al.
British Heart Journal|March 1, 1994
Are streptokinase antibodies clinically important?M Lynch, W A Littler, B L Pentecost, et al.
The American Journal of Cardiology|November 1, 1994
Overt and subclinical reactions to streptokinase in acute myocardial infarctionM Lynch, B L Pentecost, W A Littler, et al.
British Heart Journal|March 1, 1977
Changes in systolic time intervals during treatment of diabetes mellitusC A Sykes, A D Wright, J M Malins, et al.
British Heart Journal|June 1, 1984
Effect of intravenous insulin infusion on mortality among diabetic patients after myocardial infarctionD J Gwilt, M Petri, P Lamb, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Lancet (London, England)|April 17, 1993
Proteinuria with streptokinaseM Lynch, B L Pentecost, W A Littler, et al.
British Heart Journal|August 1, 1991
Immunoglobulin response to intravenous streptokinase in acute myocardial infarctionM Lynch, W A Littler, B L Pentecost, et al.
Clinical and Experimental Immunology|June 1, 1994
The significance of anti-streptokinase antibodiesM Lynch, B L Pentecost, W A Littler, et al.
British Heart Journal|November 1, 1970
Quantitative study of infarcted myocardium in cardiogenic shockC Harnarayan, M A Bennett, B L Pentecost, et al.
Lancet (London, England)|April 15, 1972
Trial of combined intramuscular and intravenous lignocaine in prophylaxis of ventricular tachyarrhythmiasS Darby, J C Cruickshank, M A Bennett, et al.
Clinical and Experimental Immunology|November 1, 1993
Why do patients develop reactions to streptokinase?M Lynch, B L Pentecost, W A Littler, et al.
British Heart Journal|March 1, 1994
Are streptokinase antibodies clinically important?M Lynch, W A Littler, B L Pentecost, et al.
The American Journal of Cardiology|November 1, 1994
Overt and subclinical reactions to streptokinase in acute myocardial infarctionM Lynch, B L Pentecost, W A Littler, et al.
British Heart Journal|March 1, 1977
Changes in systolic time intervals during treatment of diabetes mellitusC A Sykes, A D Wright, J M Malins, et al.
British Heart Journal|June 1, 1984
Effect of intravenous insulin infusion on mortality among diabetic patients after myocardial infarctionD J Gwilt, M Petri, P Lamb, et al.
Pageof 6